UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | P | R | S | T | W
Number of items: 106.

A

Anderson, VM and Bartlett, JW and Fisniku, L and Davies, GR and Rashid, W and Fox, NC and Miller, DH (2006) Sample size estimates based on hierarchical regression models of atrophy rates in relapsing-remitting multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S1 - S1). SAGE PUBLICATIONS LTD

Anderson, VM and Fox, NC and Fisniku, L and Davies, GR and Rashid, W and Miller, DH (2006) Sample size estimations to detect treatment effects in relapsing-remitting multiple sclerosis based on brain atrophy measurements from serial MRI. In: JOURNAL OF NEUROLOGY. (pp. 124 - 124). DR DIETRICH STEINKOPFF VERLAG

Anderson, VM and Fox, NC and Miller, DH (2006) Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J MAGN RESON IMAGING , 23 (5) 605 - 618. 10.1002/jmri.20550.

Audoin, B and Davies, GR and Finisku, L and Chard, DT and Thompson, AJ and Miller, DH (2006) Localization of grey matter atrophy in early RRMS - A longitudinal study. J NEUROL , 253 (11) 1495 - 1501. 10.1007/s00415-006-0264-2.

Audoin, B and Fernando, KTM and Swanton, JK and Thompson, AJ and Plant, GT and Miller, DH (2006) Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. BRAIN , 129 1031 - 1039. 10.1093/brain/awl039.

B

Bechtold, DA and Miller, SJ and Dawson, AC and Sun, Y and Kapoor, R and Berry, D and Smith, KJ (2006) Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol , 253 (12) 1542 - 1551. 10.1007/s00415-006-0204-1.

Bieniek, M and Altmann, DR and Davies, GR and Ingle, GT and Rashid, W and Sastre-Garriga, J and Thompson, AJ and Miller, DH (2006) Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J NEUROL NEUROSUR PS , 77 (9) 1036 - 1039. 10.1136/jnnp.2006.094748.
An open access publication

Bieniek, M and Altmann, DR and Davies, GR and Rashid, W and Sastre-Garriga, J and Thompson, AJ and Miller, DH (2006) Spinal cord atrophy separates early relapsing-remitting and primary progressive multiple sclerosis: a multimodal MRI study. In: JOURNAL OF NEUROLOGY. (pp. 25 - 25). DR DIETRICH STEINKOPFF VERLAG

Bilsland, L.G. and Dick, J.R.T. and Pryce, G. and Petrosino, S. and Di Marzo, V. and Baker, D. and Greensmith, L. (2006) Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. The FASEB Journal , 20 (7) pp. 1003-1005. 10.1096/fj.05-4743fje.

Black, JA and Waxman, SG and Smith, KJ (2006) Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Na<sub>v</sub>1.6 and K<sub>v</sub>1.2 at nodes of Ranvier. Brain , 129 (5) 1319 - 1329. 10.1093/brain/awl057.

C

Cercignani, M. and Alexander, D.C. (2006) Optimal acquisition schemes for in vivo quantitative magnetization transfer MRI. Magnetic Resonance in Medicine , 56 (4) pp. 803-810. 10.1002/mrm.21003.

Chapman, MD and Keir, G and Petzold, A and Thompson, EJ (2006) Measurement of high affinity antibodies on antigen-immunoblots. J IMMUNOL METHODS , 310 (1-2) 62 - 66. 10.1016/j.jim.2005.12.004.

Chard, D and Elsharkawy, A and Newbery, N (2006) Medical professionalism: the trainees' views. Clin Med , 6 (1) 68 - 71.

Charil, A and Yousry, TA and Rovaris, M and Barkhof, F and De Stefano, N and Fazekas, F and Miller, DH and Montalban, X and Simon, JH and Polman, C and Filippi, M (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". LANCET NEUROL , 5 (10) 841 - 852.

Chokkalingam, K and Tsintzas, K and Snaar, A and Norton, L and Solanky, B and Leverton, E and Morris, P and Mansell, P and Macdonald, I (2006) Hyperinsulinaemia during exercise does not suppress hepatic glycogen utilisation in patients with type 1 diabetes. In: DIABETOLOGIA. (pp. 469 - 469). SPRINGER

Ciccarelli, O and Behrens, TE and Altmann, DR and Orrell, RW and Howard, RS and Johansen-Berg, H and Miller, DH and Matthews, PM and Thompson, AJ (2006) Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. BRAIN , 129 1859 - 1871. 10.1093/brain/awl100.

Ciccarelli, O and Toosy, AT and Marsden, JE and Wheeler-Kingshott, CM and Miller, DH and Matthews, PM and Thompson, AJ (2006) Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis. J NEUROL , 253 (7) 882 - 891. 10.1007/s00415-006-0125-z.

Cipolotti, L and Bird, C and Good, T and Macmanus, D and Rudge, P and Shallice, T (2006) Recollection and familiarity in dense hippocampal amnesia: a case study. Neuropsychologia , 44 (3) pp.489 - 506.

Cipolotti, L and Bird, C and Good, T and Macmanus, D and Rudge, P and Shallice, T (2006) Recollection and familiarity in dense hippocampal amnesia: A case study. NEUROPSYCHOLOGIA , 44 (3) 489 - 506. 10.1016/j.neuropsychologia.2005.05.014.

Coles, AJ and Cox, A and Le Page, E and Jones, J and Trip, SA and Deans, J and Seaman, S and Miller, DH and Hale, G and Waldmann, H and Compston, DA (2006) The window of therapeutic opportunity in multiple sclerosis. J NEUROL , 253 (1) 98 - 108. 10.1007/s00415-005-0934-5.

Cordery, RJ and MacManus, D and Godbolt, A and Rossor, MN and Waldman, AD (2006) Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. EUR RADIOL , 16 (8) 1692 - 1698. 10.1007/s00330-005-0090-4.

D

Dale, RC and Candler, PM and Church, AJ and Wait, R and Pocock, JM and Giovannoni, G (2006) Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J NEUROIMMUNOL , 172 (1-2) 187 - 197. 10.1016/j.jneuroim.2005.10.014.

Dalton, CM and Miszkiel, KA and O'Connor, PW and Plant, GT and Rice, GPA and Miller, DH (2006) Ventricular enlargement in MS - One-year change at various stages of disease. NEUROLOGY , 66 (5) 693 - 698.

Drapier, S and Swanton, J and Altmann, D and Fernando, KTM and Dalton, C and Thompson, AJ and Plant, G and Miller, DH (2006) Increasing cord atrophy in clinical isolated syndrome group: a 5-year study. In: MULTIPLE SCLEROSIS. (pp. S176 - S176). SAGE PUBLICATIONS LTD

E

Edan, G and Freedman, MS and Kappos, L and Polman, CH and Hartung, HP and Miller, DH and Montalban, X and Bauer, L and Pohl, C and Sandbrink, R (2006) Betaferon(R) in newly emerging multiple sclerosis for initial treatment (BENEFIT): Safety, tolerability, and adherence. EUR J NEUROL , 13 39 - 39.

F

Fernando, KTM and Chard, DT and McLean, MA and Altmann, DR and Swanton, JK and Gordon, RM and Miszkiel, KA and Plant, GT and Thompson, AJ and Miller, DH (2006) Serial MR spectroscopy of the white matter in the first 3 years after the onset of a clinically isolated syndrome suggestive of multiple sclerosis. In: JOURNAL OF NEUROLOGY. (pp. 25 - 26). DR DIETRICH STEINKOPFF VERLAG

Fernando, KTM and Chard, DT and McLean, MA and Swanton, JK and Gordon, RM and Altmann, DR and Dalton, CM and Miszkiel, KA and Plant, GT and Thompson, AJ and Miller, DH (2006) Raised white matter myo-inositol after a clinically isolated syndrome is associated with the subsequent development of multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 130 - 130). B M J PUBLISHING GROUP

Fernando, KTM and Chard, DT and McLean, MA and Swanton, JK and Miszkiel, KA and Gordon, RM and Altmann, DR and Plant, GT and Thompson, AJ and Miller, DH (2006) Metabolite changes in the white matter 3 years after a clinically isolated syndrome suggestive of multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S41 - S41). SAGE PUBLICATIONS LTD

Fisniku, L and Brex, P and Thompson, AJ and Miller, DH (2006) Disability after 20 years in a multiple sclerosis cohort followed from onset with a clinically isolated syndrome. In: JOURNAL OF NEUROLOGY. (pp. 7 - 7). DR DIETRICH STEINKOPFF VERLAG

Freedman, MS and Kappos, L and Polman, CH and Hartung, HP and Edan, G and Miller, DH and Montalban, X and Bauer, L and Dahms, S and Pohl, C and Sandbrink, R (2006) Analysis of neutralising antibodies in the Betaferon (R) in newly emerging multiple sclerosis for initial treatment (BENEFIT) study. In: JOURNAL OF NEUROIMMUNOLOGY. (pp. 208 - 208). ELSEVIER SCIENCE BV

Furby, J and Hayton, T and Smith, KJ and Altmann, D and Brenner, R and Chataway, J and Fox, NC and Hughes, RAC and Miller, DH and Kapoor, R (2006) A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S228 - S228). SAGE PUBLICATIONS LTD

G

Garrard, P and Schott, JM and MacManus, DG and Hodges, JR and Fox, NC and Waldman, AD (2006) Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia. COGN BEHAV NEUROL , 19 (4) 185 - 189.

Garrard, P and Schott, JM and MacManus, DG and Hodges, JR and Fox, NC and Waldman, AD (2006) Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia. Cognitive and Behavioral Neurology , 19 (4) pp.185 - 189.

Giovannoni, G and Chapman, MD and Thompson, EJ (2006) The role of antibody affinity for specific antigens in the differential diagnosis of inflammatory nervous system disorders. J NEUROIMMUNOL , 180 (1-2) 29 - 32. 10.1016/j.jneuroim.2006.06.033.

Giovannoni, G and O'Connor, P and Havrdova, E and Hutchinson, M and Kappos, L and Miller, D and PhillipS, JT and Polman, C and Lublin, F and Wajgt, A and Lynn, F and Panzara, M and Sandrock, A (2006) The immunogenicity of natalizumab in patients with multiple sclerosis. In: CLINICAL IMMUNOLOGY. (pp. S116 - S116). ACADEMIC PRESS INC ELSEVIER SCIENCE

Godbolt, AK and Waldman, AD and MacManus, DG and Schott, JM and Frost, C and Cipolotti, L and Fox, NC and Rossor, MN (2006) MRS shows abnormalities before symptoms in familial Alzheimer disease. NEUROLOGY , 66 (5) 718 - 722.

Gold, R and Havrdova, E and Kappos, L and Limmroth, V and Miller, D and Polman, C and Yang, M and Eraksoy, M and Meluzinova, E and Rektor, I and O'Neill, GN (2006) Safety of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remitting multiple sclerosis: results of a phase 2 study. In: JOURNAL OF NEUROLOGY. (pp. 144 - 145). DR DIETRICH STEINKOPFF VERLAG

H

Haroon, HA and Lambon-Ralph, MA and Watson, Y and Ciccarelli, O and Wheeler-Kingshott, CAM and Alexander, DC and Luzzi, S and Parker, GJM (2006) Auditory-language networks involving the superior temporal gyrus: patterns of connection and lateralization. In: Proc. Intl. Soc. Mag. Reson. Med. (pp. 769 - 769).

Hartung, HP and Kappos, L and Polman, CH and Freedman, MS and Edan, G and Miller, DH and Montalban, X and Barkhof, F and Bauer, L and Dahms, S and Pohl, C and Sandbrink, R (2006) Betaferon(R) in newly emerging multiple sclerosis for initial treatment (BENEFIT): Clinical outcomes. EUR J NEUROL , 13 38 - 38.

Henderson, APD and Trip, SA and Garway-Heath, DF and Plant, GT and Miller, DH (2006) Retinal nerve fibre layer atrophy in primary progressive multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S37 - S38). SAGE PUBLICATIONS LTD

Henley, SMD and Frost, C and MacManus, DG and Warner, TT and Fox, NC and Tabrizi, SJ (2006) Increased rate of whole-brain atrophy over 6 months in early Huntington disease. NEUROLOGY , 67 (4) 694 - 696.

Hooper, C and Pocock, JM (2006) The functions of glia - an overview. UNSPECIFIED

Hutchinson, M and O'Connor, PW and Havrdova, E and Kappos, L and Miller, DH and Phillips, JT and Polman, CH and Lublin, FD and Giovannoni, G and Wajgt, A and Lynn, F and Panzara, MA and Sandrock, AW (2006) The effects of natalizumab on disability and health-related quality of life in patients with relapsing MS. EUR J NEUROL , 13 38 - 38.

J

Jovanovic, A and Gerrard, J and Solanky, B and Leverton, E and Snaar, JEM and Morris, PG and Taylor, R (2006) The second meal effect results from priming of glycogen synthesis in muscle and liver and can be mimicked by administration of arginine. In: DIABETOLOGIA. (pp. 342 - 343). SPRINGER

Jovanovic, A and Ravikumar, B and Solanky, B and Leverton, E and Snaar, JEM and Morris, PG and Taylor, R (2006) Potential for improving blood glucose control: The second meal effect and enhanced muscle glycogen synthesis. In: DIABETES. (pp. A334 - A334). AMER DIABETES ASSOC

K

Kallmann, B and Spech, E and Kroner, A and Petzold, A and Obojes, K and Miller, DH and Thompson, A and Giovannoni, G and Rieckmann, P (2006) Different TRADD expression discriminates between multiple sclerosis disease subtypes. In: MULTIPLE SCLEROSIS. (pp. S221 - S222). SAGE PUBLICATIONS LTD

Kallmann, BA and Spech, E and Kroner, A and Petzold, A and Miller, D and Thompson, A and Giovannoni, G and Rieckmann, P (2006) Differences in TRADD expression indicated by array analysis discriminates between NIS disease subtypes. In: JOURNAL OF NEUROIMMUNOLOGY. (pp. 202 - 202). ELSEVIER SCIENCE BV

Kapoor, R and Smith, KJ (2006) Pathophysiology of multiple sclerosis: demyelination and axonal injury. In: Schapira, AHV, (ed.) Neurology and clinical neuroscience. (1002 - 1013). Mosby/Elsevier: Philadelphia.

Kappos, L and Miller, DH and MacManus, DG and Gold, R and Havrdova, E and Limmroth, V and Polman, CH and Schmierer, K and Yousry, TA and Yang, M and Eraksoy, M and Meluzinova, E and Rektor, I and O'Neill, G (2006) BG00012, a novel oral fumarate, is effective in patients with relapsing-remitting multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S85 - S85). SAGE PUBLICATIONS LTD

Kappos, L and Miller, DH and MacManus, DG and Gold, R and Havrdova, E and Limmroth, V and Polrnan, C and Schmierer, K and Yousry, T and Long, M and Eraksoy, M and Meluzinova, E and Rektor, I and O'Neill, GN (2006) Efficacy of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remitting multiple sclerosis: results of a phase 2 study. In: JOURNAL OF NEUROLOGY. (pp. 27 - 27). DR DIETRICH STEINKOPFF VERLAG

Kappos, L and Polman, CH and Freedman, MS and Edan, G and Hartung, HP and Miller, DH and Montalban, X and Barkhof, F and Bauer, L and Jakobs, P and Pohl, C and Sandbrink, R and BENEFIT Study Grp, (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. NEUROLOGY , 67 (7) 1242 - 1249.

Karrenbauer, VD and Leoni, V and Lim, ET and Giovannoni, G and Ingle, GT and Sastre-Garriga, J and Thompson, AJ and Rashid, W and Davies, G and Miller, DH and Bjorkhem, I and Masterman, T (2006) Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. CLIN NEUROL NEUROSUR , 108 (5) 456 - 460. 10.1016/j.clineuro.2005.07.010.

Korteweg, T and Tintore, M and Uitdehoog, B and Rovira, A and Frederiksen, J and Miller, D and Fernando, K and Filippi, M and Agosta, F and Rocca, M and Fazekas, F and Enzinger, C and Matthews, P and Parry, A and Polman, C and Montalban, X and Barkhof, F (2006) MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. LANCET NEUROL , 5 (3) 221 - 227. 10.1016/S1474-4422(06)70353-2.

Krumbholz, M and Theil, D and Cepok, S and Hemmer, B and Hofbauer, M and Farina, C and Derfuss, T and Arzberger, T and Sinicina, I and Hartle, C and Newcombe, J and Hohlfeld, R and Meinl, E (2006) The homeostatic chemokine CCL19 is constitutively expressed in the CNS, up-regulated in multiple sclerosis lesions, and is correlated with intrathecal IgG production. In: JOURNAL OF NEUROIMMUNOLOGY. (pp. 142 - 142). ELSEVIER SCIENCE BV

Krumbholz, M and Theil, D and Cepok, S and Hemmer, B and Kivisakk, P and Ransohoff, RM and Hofbauer, M and Farina, C and Derfuss, T and Hartle, C and Newcombe, J and Hohlfeld, R and Meinl, E (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. BRAIN , 129 200 - 211. 10.1093/brain/awh680.

Kuhle, J and Kappos, L and Pohl, C and Mehling, M and Edan, G and Freedman, M and Hartung, HP and Miller, DH and Montalban, X and Polman, C and Barkhof, F and Bauer, L and Dahms, S and Lindberg, RLP and Sandbrink, R (2006) Prognostic relevance of antimyelin antibodies for progression to multiple sclerosis after a first demyelinating event: results from the BENEFIT study. In: MULTIPLE SCLEROSIS. (pp. S17 - S17). SAGE PUBLICATIONS LTD

Kuhle, J and Mehling, M and Hartung, HP and Freedman, MS and Polman, CH and Edan, G and Miller, DH and Montalban, X and Bauer, L and Dahms, S and Pohl, C and Sandbrink, R and Lindberg, R and Kappos, L (2006) Prognostic relevance of antimyelin antibodies for the progression to multiple sclerosis after a first demyelinating event: Results of the BENEFIT trial. In: JOURNAL OF NEUROIMMUNOLOGY. (pp. 55 - 55). ELSEVIER SCIENCE BV

L

Lanyon, R and Dalton, C and Swanton, J and Plant, GT and Thompson, AJ and Miller, DH (2006) Perceptions of MRI research in patients with clinically isolated syndromes. In: MULTIPLE SCLEROSIS. (pp. S110 - S111). SAGE PUBLICATIONS LTD

Li, DKB and Held, U and Petkau, J and Daumer, M and Barkhof, F and Fazekas, F and Frank, JA and Kappos, L and Miller, DH and Simon, JH and Wolinsky, JS and Filippi, M and Sylvia Lawry Centre MS Res, (2006) MRI T2 lesion burden in multiple sclerosis - A plateauing relationship with clinical disability. NEUROLOGY , 66 (9) 1384 - 1389.

M

Manfredonia, F and Khaleeli, Z and Ciccarelli, O and Sastre-Garriga, J and Tozer, DJ and Miller, DH and Thompson, AJ (2006) A longitudinal study of T1 relaxation time in normal appearing white matter and grey matter in early primary progressive multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S183 - S183). SAGE PUBLICATIONS LTD

Manton, DJ and Chaturvedi, A and Hubbard, A and Lind, MJ and Lowry, M and Maraveyas, A and Pickles, MD and Tozer, DJ and Turnbull, LW (2006) Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. BRIT J CANCER , 94 (3) 427 - 435. 10.1038/sj.bjc.6602948.

Manton, DJ and Chaturvedi, A and Hubbard, A and Lind, MJ and Lowry, M and Maraveyas, A and Pickles, MD and Tozer, DJ and Turnbull, LW (2006) Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy (vol 94, pg 1554, 2006). BRIT J CANCER , 94 (10) 1554 - 1554. 10.1038/sj.bjc.6603165.

Miller, DH (2006) Role of MRI in diagnosing multiple sclerosis - Magnetic resonance imaging is valuable. BRIT MED J , 332 (7548) 1034 - 1034.

Mills, K. and Mills, P. and Jackson, M. and Worthington, V. and Beesley, C. and Mann, A. and Clayton, P. and Grunewald, S. and Keir, G. and Young, L. and Langridge, J. and Mian, N. and Winchester, B. (2006) Diagnosis of congenital disorders of glycosylation type-I using protein chip technology. Proteomics , 6 (7) pp. 2295-2304. 10.1002/pmic.200500682.

Mills, K. and Mills, P. and Jackson, M. and Worthington, V. and Beesley, C. and Mann, A. and Clayton, P. and Grunewald, S. and Keir, G. and Young, L. and Langridge, J. and Mian, N. and Winchester, B. (2006) Diagnosis of congenital disorders of glycosylation type-I using protein chip technology. PROTEOMICS , 6 (7) pp. 2295-2304. 10.1002/pmic.200500682.

Montalban, X and Polman, CH and Kappos, L and Freedman, MS and Edan, G and Hartung, HP and Miller, DH and Barkhof, F and Bauer, L and Dahms, S and Pohl, C and Sandbrink, R (2006) Betaferon(R) in newly emerging multiple sclerosis for initial treatment (BENEFIT): Subgroup analysis. EUR J NEUROL , 13 27 - 28.

P

Petzold, A and Keir, G and Kay, A and Kerr, M and Thompson, EJ (2006) Axonal damage and outcome in subarachnoid haemorrhage. J NEUROL NEUROSUR PS , 77 (6) 753 - 759. 10.1136/jnnp.2005.085175.
An open access publication

Petzold, A. and Eikelenboom, M.J. and Keir, G. and Polman, C.H. and Uitdehaag, B.M.J. and Thompson, E.J. and Giovannoni, G. (2006) The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers. Multiple Sclerosis , 12 (3) pp. 325-328. 10.1191/135248505ms1277oa.
An open access version is available from UCL Discovery
 file

Petzold, A. and Sharpe, L.T. and Keir, G. (2006) Spectrophotometry for cerebrospinal fluid pigment analysis. Neurocritical care , 4 (2) pp. 153-62. 10.1385/NCC:4:2:153.
An open access version is available from UCL Discovery
 file

Phillips, JT and O'Connor, PW and Havrdova, E and Hutchinson, M and Kappos, L and Miller, DH and Polman, CH and Lublin, FD and Giovannoni, G and Wajgt, A and Lynn, F and Panzara, MA (2006) Infusion-related hypersensitivity reactions during natalizumab treatment. NEUROLOGY , 67 (9) 1717 - 1718.

Pocock, JM and Hooper, C and East, E and Jones, J (2006) Cell death pathways and the immune response. In: Yenari, MA and Giffard, RG, (eds.) Glia and Inflammation in Neurodegenerative Disease. (41 - 62). Nova Science Publishers Inc: New York.

Polman, CH and O'Connor, PW and Havrdova, E and Hutchinson, M and Kappos, L and Miller, DH and Phillips, JT and Lublin, FD and Giovannoni, G and Wajgt, A and Toal, M and Lynn, F and Panzara, MA and Sandrock, AW and AFFIRM Investigators, (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. NEW ENGL J MED , 354 (9) 899 - 910.

Powell, HWR and Parker, GJM and Alexander, DC and Symms, MR and Boulby, PA and Wheeler-Kingshott, CAM and Barker, GJ and Noppeney, U and Koepp, MJ and Duncan, JS (2006) Hemispheric asymmetries in language-related pathways: A combined functional MPI and tractography study. NEUROIMAGE , 32 (1) 388 - 399. 10.1016/j.neuroimage.2006.03.011.

R

Ramio-Torrenta, L and Sastre-Garriga, J and Ingle, GT and Davies, GR and Ameen, V and Miller, DH and Thompson, AJ (2006) Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J NEUROL NEUROSUR PS , 77 (1) 40 - 45. 10.1136/jnnp.2004.052316.
An open access publication

Rashid, W and Davies, GR and Chard, DT and Griffin, CM and Altmann, DR and Gordon, R and Kapoor, R and Thompson, AJ and Miller, DH (2006) Upper cervical cord area in early relapsing-remitting multiple sclerosis: Cross-sectional study of factors influencing cord size. J MAGN RESON IMAGING , 23 (4) 473 - 476. 10.1002/jmri-i.20545.

Rashid, W and Davies, GR and Chard, DT and Griffin, CM and Altmann, DR and Gordon, R and Kapoor, R and Thompson, AJ and Miller, DH (2006) Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size. J Magn Reson Imaging , 23 (4) 473 - 476. 10.1002/jmri.20545.

Rashid, W and Davies, GR and Chard, DT and Griffin, CM and Altmann, DR and Gordon, R and Thompson, AJ and Miller, DH (2006) Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J NEUROL NEUROSUR PS , 77 (1) 51 - 55. 10.1136/jnnp.2005.068338.
An open access publication

Rees, JH and Weil, RS and Waldman, AD and Jager, HR and Benton, CE and Tozer, DJ and Altman, DR and Tofts, PS (2006) Gadolinium enhancement index predicts transformation in adult low-grade gliomas. EUR J NEUROL , 13 280 - 280.

Rejdak, K and Empl, M and Giffin, NJ and Afridi, SK and Petzold, A and Stelmasiak, Z and Thompson, EJ and Goadsby, PJ and Kaube, H and Giovannoni, G (2006) Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patients. EUR J NEUROL , 13 (12) 1346 - 1351. 10.1111/j.1468-1331.2006.01509.x.

Rejdak, K and Leary, SM and Petzold, A and Stelmasiak, Z and Thompson, AJ and Miller, DH and Giovannoni, G (2006) Raised urinary neopterin excretion is associated with a better clinical outcome in PP-MS patients treated with interferon beta-1a. In: MULTIPLE SCLEROSIS. (pp. S185 - S186). SAGE PUBLICATIONS LTD

Rovaris, M and Judica, E and Benedetti, B and Barkhof, E and De Stefano, N and Korteweg, T and Miller, D and Montalban, X and Polman, C and Rovira, A and Sastre-Garriga, J and Thompson, A and Filippi, M (2006) Multiparametric MRI assessment of brain and cord damage in primary progressive multiple sclerosis: a large-scale, multicentre study. In: JOURNAL OF NEUROLOGY. (pp. 8 - 8). DR DIETRICH STEINKOPFF VERLAG

Rovaris, X and Judica, E and Perego, E and Benedetti, B and Barkhof, F and De Stefano, N and Khaleeli, Z and Korteweg, T and Miller, DH and Montalban, X and Polman, C and Rovira, A and Sastre-Garriga, J and Thompson, AJ and Filippi, M (2006) Multiparametric MRI assessment of brain and cord damage in primary progressive multiple sclerosis: a large-scale, multicentre study. In: MULTIPLE SCLEROSIS. (pp. S47 - S47). SAGE PUBLICATIONS LTD

S

Saikali, P and Newcombe, J and Chen, Z and Freedman, M and Antel, J and Arbour, N (2006) Human glial cells express NKG2D ligands that trigger immune cytotoxicity: Implications for multiple sclerosis. In: JOURNAL OF NEUROIMMUNOLOGY. (pp. 194 - 194). ELSEVIER SCIENCE BV

Samson, RS and Thornton, JS and McLean, MA and Williams, SCR and Tofts, PS (2006) H-1-MRS internal thermometry in test-objects (phantoms) to within 0.1 K for quality assurance in long-term quantitative MR studies. NMR BIOMED , 19 (5) 560 - 565. 10.1002/nbm.1033.

Samson, RS and Wheeler-Kingshott, CAM and Symms, MR and Tozer, DJ and Tofts, PS (2006) A simple correction for B-1 field errors in magnetization transfer ratio measurements. MAGN RESON IMAGING , 24 (3) 255 - 263. 10.1016/j.mri.2005.10.025.

Schmierer, K and Miller, DH (2006) Making sense of magnetic resonance measures in multiple sclerosis: The post mortem evidence. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1389 - 1389). B M J PUBLISHING GROUP

Schmierer, K and Parkes, HG and So, PW and Miller, DH and Yousry, TA (2006) High field-high yield: detecting multiple sclerosis white matter lesions at 9.4 Tesla. In: MULTIPLE SCLEROSIS. (pp. S45 - S45). SAGE PUBLICATIONS LTD

Schott, JM and Frost, C and Whitwell, JL and MacManus, DG and Boyes, RG and Rossor, MN and Fox, NC (2006) Combining short interval MRI in Alzheimer's disease. J NEUROL , 253 (9) 1147 - 1153. 10.1007/s00415-006-0173-4.

Sepulcre, J and Sastre-Garriga, J and Cercignani, M and Ingle, GT and Miller, DH and Thompson, AJ (2006) Regional gray matter atrophy in early primary progressive multiple sclerosis - A voxel-based morphometry study. ARCH NEUROL-CHICAGO , 63 (8) 1175 - 1180.

Skundric, DS and Cai, J and Cruikshank, WW and Gveric, D (2006) Production of IL-16 correlates with CD4+Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions. J NEUROINFLAMM , 3 , Article 13. 10.1186/1742-2094-3-13.
An open access publication

Smith, KJ (2006) Axonal protection in multiple sclerosis--a particular need during remyelination? Brain , 129 (12) 3147 - 3149.

Smith, KJ (2006) [Pathophysiology of multiple sclerosis]. La Revue du Praticien , 56 (12) 1299 - 1303.

Soon, D and Altmann, DR and Tofts, DS and Miller, DH (2006) Subtle blood brain barrier disruption in chronic non-enhancing lesions in MS. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 131 - 132). B M J PUBLISHING GROUP

Swanton, JK and Fernando, K and Dalton, CM and Miszkiel, KA and Thompson, AJ and Plant, GT and Miller, DH (2006) Evaluation of modified MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 140 - 140). B M J PUBLISHING GROUP

Swanton, JK and Fernando, K and Dalton, CM and Miszkiel, KA and Thompson, AJ and Plant, GT and Miller, DH (2006) Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J NEUROL NEUROSUR PS , 77 (7) , Article 830. 10.1136/jnnp.2005.073247.
An open access publication

Swanton, JK and Fernando, K and Dalton, CM and Miszkiel, KA and Thompson, AJ and T Plant, G and Miller, DH (2006) Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison. J NEUROL NEUROSUR PS , 77 (9) 1070 - 1072. 10.1136/jnnp.2006.090910.
An open access publication

Swanton, JK and Fernando, KTM and Dalton, CM and Miszkiel, KA and Thompson, AJ and Plant, GT and Miller, DH (2006) Comparing the 2005 and 2001 McDonald criteria for the diagnosis of multiple sclerosis in clinically isolated syndrome patients. In: JOURNAL OF NEUROLOGY. (pp. 123 - 124). DR DIETRICH STEINKOPFF VERLAG

T

Tiberio, M and Chard, DT and Altmann, DR and Davies, G and Griffin, CM and McLean, MA and Rashid, W and Sastre-Garriga, J and Thompson, AJ and Miller, DH (2006) Metabolite changes in early relapsing-remitting multiple sclerosis - A two year follow-up study. J NEUROL , 253 (2) 224 - 230. 10.1007/s00415-005-0964-z.

Tofts, PS and Steens, SCA and Cercignani, W and Admiraal-Behloul, F and Hofman, PAM and van Osch, MJP and Teeuwisse, WM and Tozer, DJ and van Waesberghe, JHTM and Yeung, R and Barker, GJ and van Buchem, MA (2006) Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differences. MAGN RESON MATER PHY , 19 (4) 209 - 222. 10.1007/s10334-006-0049-8.

Tozer, DJ and Davies, GR and Altmann, DR and Miller, DH and Tofts, PS (2006) Principal component and linear discriminant analysis of T-1 histograms of white and grey matter in multiple sclerosis. MAGN RESON IMAGING , 24 (6) 793 - 800. 10.1016/j.mri.2005.08.002.

Trip, SA and Schlottmann, P and Jones, S and Garway-Heath, DF and Thompson, A and Plant, G and Miller, DH (2006) Optic nerve head topography in optic neuritis. In: MULTIPLE SCLEROSIS. (pp. S183 - S184). SAGE PUBLICATIONS LTD

Trip, SA and Schlottmann, PG and Jones, SJ and Garway-Heath, DF and Thompson, AJ and Plant, GT and Miller, DH (2006) Quantification of optic nerve head topography in optic neuritis: a pilot study. BRIT J OPHTHALMOL , 90 (9) 1128 - 1131. 10.1136/bjo.2006.092031.
An open access publication

Trip, SA and Schlottmann, PG and Jones, SJ and Li, WY and Garway-Heath, DF and Thompson, AJ and Plant, GT and Miller, DH (2006) Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy. NEUROIMAGE , 31 (1) 286 - 293. 10.1016/j.neuroimage.2005.11.051.

Trip, SA and Wheeler-Kingshott, C and Jones, SJ and Li, WY and Barker, GJ and Thompson, AJ and Plant, GT and Miller, DH (2006) Optic nerve diffusion tensor imaging in optic neuritis. NEUROIMAGE , 30 (2) 498 - 505. 10.1016/j.neuroimage.2005.09.024.

W

Waldman, AD and Cordery, RJ and MacManus, DG and Godbolt, A and Collinge, J and Rossor, MN (2006) Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy. NEURORADIOLOGY , 48 (6) 428 - 433. 10.1007/s00234-006-0068-1.

Wheeler-Kingshott, CAM and Trip, SA and Symms, MR and Parker, GJM and Barker, GJ and Miller, DH (2006) In vivo diffusion tensor imaging of the human optic nerve: Pilot study in normal controls. MAGN RESON MED , 56 (2) 446 - 451. 10.1002/mrm.20964.

This list was generated on Sat May 25 09:18:34 2013 BST.